Partner search
A sponsor begins comparing CDMO, tools, or supply partners before the shortlist is visible.
For Life sciences consultants
Be the first call, not the second opinion.
ARIA tracks partner movement, buyer changes, and competitive context across the sponsors you serve, and turns it into a sourced brief or client update.
Buying windows ARIA watches
ARIA watches four triggers for life sciences consultants, each visible before a shortlist or partner search goes public.
A sponsor beginning a partner search. A company you cover changing phase or funding. A new BD, CMC or strategy owner arriving. A competitor or supplier move that reshapes the account landscape.
Portfolio movement
A company you cover changes phase, funding, buyer, or manufacturing plan.
New decision-maker
A new BD, CMC, or strategy owner changes who should be reached.
Competitive move
A competitor, partner, or supplier changes the account landscape.
A trial is registered within 21 days of first enrolment
An applicable clinical trial must be registered no later than 21 calendar days after the first human subject is enrolled.
A programme entering the clinic becomes public on a fixed clock. The rule requires registration no later than 21 calendar days after the first human subject is enrolled, so a sponsor cannot start enrolling quietly and disclose at leisure. For an advisor tracking who is about to need outside help, that is a dated, checkable event rather than an inference from hiring or press.
Source: 42 CFR 11.24. ARIA reads the primary record, not a summary of it, and links each claim back to the filing it came from.
How to rank the accounts worth working
Rank on four things: whether a dated decision exists, how recently they funded, whether a new decision-maker has arrived, and what you can staff.
Rank on four things. Whether the account faces a decision with a date on it, how recently it was funded, whether a new decision-maker has arrived, and whether you can staff the work now. Advisory work is bought at decisions rather than at needs, so the first of those carries the most weight.
A decision with a date
A partner search, a phase change, or a shift in manufacturing plan puts a decision in front of the sponsor with a date attached. An account that fits your practice but faces no such decision is a relationship to maintain rather than a proposal to write this quarter, and ranking on fit alone confuses the two.
Funding recency
An engagement has to be paid for. A recent raise, or a funding event at a portfolio company, is the budget signal, and it is disclosed publicly before the spending appears anywhere else. A sponsor that raised recently can commission work that one running lean cannot, whatever the fit looks like on paper.
New decision-maker
A new BD, CMC or strategy owner arrives without a settled view and with licence to bring in outside help, which makes it the highest converting moment to reach an account. It is also the shortest lived, because within a quarter or two the view has formed and the preferred advisors have been chosen.
What you can staff
Score each opportunity against the practice areas and the people you can actually put on it now. Work you win and cannot staff costs more than work you lose, so ARIA ranks on what you can take rather than on what you would like to take.
ARIA scores each account on these and shows the evidence behind the score, so the person reviewing it can disagree. Nothing is contacted without a person approving it first.
What ARIA prepares for you
For each, ARIA prepares a sourced partner brief, an account context readout, and a client follow-up draft, linked to its source.
Every claim links to the primary record, and nothing goes out without your approval.
Sourced partner briefAccount context readoutClient follow-up draft
A live deal, with the technical wedge to win it.
Your firm, your modality, your region. ARIA finds a live commercial opening, reasons the technical wedge to win it, and stages the outreach.
Reasoning trace
- Point ARIA at your firm and run. It finds a real recruiting program and prepares the read here, each step sourced.
Sourced where a source exists · held back where none does
Prepared readTriangulated
Prepared for your firm
Track partner moves first
Point ARIA at your firm and run. A partner or deal signal, the partner read, and your first-call question compose in right here, every claim sourced.
CDMO business development
The right programs, not more leads.
ARIA scores fresh raises, phase changes, and de-risking sponsors against your capability and open capacity, then drafts the outreach.
ARIA watches
Funding event
A target biotech raises or extends runway before your BD team knows to reach out.
Phase change
A lead program advances and the sponsor starts pressure-testing manufacturing capacity.
New CMC owner
A new technical decision-maker resets vendor preference and partner selection.
Supply-chain de-risking
A sponsor starts reducing dependence on one geography or one incumbent CDMO.
ARIA prepares
Program-fit briefCapacity-timed outreachCRM opportunity note
You approve
Every claim sourced. Nothing sends on its own.
Bioprocessing equipment and consumables
Place instruments ahead of the curve.
ARIA flags the funded programs that are scaling, and surfaces competitive moves on your installed base before they cost you a reorder.
ARIA watches
Spec-in window
A process characterized on your platform tends to scale on it. The vendor is chosen when the URS is written, not at the PO.
Competitor quote
A rival appears in an installed-base account before your rep knows the account is evaluating.
Reorder window
Consumable pull-through starts to slip across sites before renewal risk shows in CRM.
Capacity expansion
A facility or suite expansion creates equipment demand before the budget is public.
ARIA prepares
Equipment-fit briefCompetitive save motionRep-ready talk track
You approve
Every claim sourced. Nothing sends on its own.
Reagent and specialty suppliers
Nobody announces they're switching.
ARIA finds where that budget sits, flags substitution risk before reorder volume drops, and prepares the account-specific reason to call.
ARIA watches
Grant cycle
A lab or diagnostics group gets funded and reagent demand moves before the team sees a purchase signal.
Spec-in window
A program in development locks its materials in early, often by Phase 1. The reagent validated now rides the program.
Substitution risk
A key account starts comparing alternative reagents before reorder volume drops.
Budget window
A lab has active spend now, while broader market demand still looks soft.
ARIA prepares
Account-specific reason to callReorder defense noteBudget-window outreach
You approve
Every claim sourced. Nothing sends on its own.
Life sciences consultants
Be the first call, not the second opinion.
ARIA tracks partner movement, buyer changes, and competitive context across the sponsors you serve, and turns it into a sourced brief or client update.
ARIA watches
Partner search
A sponsor begins comparing CDMO, tools, or supply partners before the shortlist is visible.
Portfolio movement
A company you cover changes phase, funding, buyer, or manufacturing plan.
New decision-maker
A new BD, CMC, or strategy owner changes who should be reached.
Competitive move
A competitor, partner, or supplier changes the account landscape.
ARIA prepares
Sourced partner briefAccount context readoutClient follow-up draft
You approve
Every claim sourced. Nothing sends on its own.
Questions buyers ask
- How do consultants track partner and competitor moves?
- The underlying events are public, including partnership filings, trial registrations, funding rounds, facility announcements and leadership changes, but they are scattered across registries that nobody has time to read daily. ARIA watches them continuously and assembles the relevant ones into a sourced brief per account.
- How quickly does a new clinical trial become public?
- Within three weeks of the first patient. An applicable clinical trial must be registered no later than 21 calendar days after the first human subject is enrolled, so a sponsor cannot begin enrolling quietly and disclose whenever it suits them. For an advisor tracking which sponsors are about to need outside help, that is a dated and checkable event rather than an inference drawn from hiring or press coverage.
- What signals show a sponsor is starting a partner search?
- A fresh raise, a programme entering a phase that needs outside capacity, a new BD or CMC decision-maker, and early supply-chain diversification. These typically precede a visible shortlist.
- How should life sciences consultants prioritise prospective clients?
- Rank on four inputs. Whether the account faces a decision with a date on it, such as a partner search, a phase change, or a change in manufacturing plan, because advisory work is bought at decisions rather than at needs. How recently it was funded, since an engagement has to be paid for and financing is disclosed publicly before the spending shows up. Whether a new BD, CMC or strategy owner has arrived, which is the highest converting moment to reach an account and the shortest lived. And whether you can staff the work now, because work you win and cannot staff costs more than work you lose.
- How do I turn market signals into a client-ready brief?
- The work is retrieval, then interpretation, then citation. ARIA does the first pass, pulling the primary records, linking each claim to its source, and drafting the readout, so the judgement you add is yours rather than the assembly.
- Does ARIA contact anyone on its own?
- No. Nothing sends without a person's approval, and every approved action is logged and reversible.
Put ARIA on your accounts.
One workflow, your systems, your team's approval. Book a short walkthrough and see your first pass.